We support national tuberculosis programs in the Asia-Pacific region to address drug-resistant tuberculosis.
Tuberculosis (TB) is the world’s leading infectious disease killer. Drug-resistant TB (DR-TB) is an urgent threat to global and individual health security.
We're contributing towards global targets to eliminate TB as a public health threat through partnerships, community engagement, technical assistance to national programs and implementation of innovation and research.
To eliminate tuberculosis, it's critical to first address drug-resistant tuberculosis as a crisis and threat to global health security. Our focus is on the Asia-Pacific region, which carries most of the global tuberculosis burden. Utilising our breadth and depth in research, international development and public health, we're providing support to national tuberculosis programs to strengthen health systems, design and evaluate programs and build capacity for operational research.
Papua New Guinea has been increasingly recognised as a hotspot for tuberculosis and drug-resistance. The RID-TB project continues to make significant progress towards combatting the major drug-resistant tuberculosis outbreak on Daru Island in the Western Province, which has rates that are among the highest reported globally.
Burnet Institute is a key technical partner in the Papua New Guinea government's emergency response to drug-resistant tuberculosis, working in collaboration with partners funded by the Australian Government, including World Vision.
The ZTB team is working towards eliminating tuberculosis and providing accessible services with treatment and prevention options.
As part of our commitment to developing improved diagnostics for tuberculosis, we're collaborating with China’s Institute for Pathogen Biology.
Tuberculosis (TB) is the second leading cause of death in Papua New Guinea). There is an urgent need for accurate, battery operated and cheaper TB diagnostics.
This project aims to implement and evaluate a model of community-based drug-resistant tuberculosis care to facilitate scale-up in Myanmar and other similar resource-constrained settings.
This operational research course supports institutions and key leaders in the tuberculosis response across Indonesia.
This project explores zoonotic tuberculosis—tuberculosis that occurs in animals and is transmitted to humans
Research into the increasing burden of non-communicable diseases and continuing high prevalence of tuberculosis and HIV in Papua New Guinea will benefit from new funding from the National Health and Medical Research Council.